IP Group - Detailed look at the deeptech portfolio
IP Group has built a commendable portfolio of businesses developing breakthrough technologies, with an aggregate value of more than £200m at...
215 Views
IP Group - Remaining on track despite tough markets
IP Group’s private portfolio valuations remained broadly stable in H123, with its c 4.1% NAV decline in total return (TR) terms mostly due to a de...
212 Views
IP Group - Deep dive into the life sciences portfolio
We consider IP Group a compelling healthcare play with 31% of its end-2022 portfolio invested in life sciences companies, or 47% including Oxford...
236 Views
IP Group - Priority companies making progress in 2022
IP Group’s NAV per share came in at 132.9p at end-2022, only 2% below the end-June 2022 level. The NAV decline during 2022 was primarily due to the...
352 Views
IP Group - Focus on high-conviction plays to drive returns
IP Group’s NAV per share came in at 132.9p at end 2022, down 20% year-on-year in total return terms but only 2% below the end-June 2022 level. The...
264 Views